- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- January 2023
- 87 Pages
From €3293EUR$3,450USD£2,759GBP
- Report
- January 2023
- 94 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- January 2023
- 94 Pages
Middle East, Africa
From €3293EUR$3,450USD£2,759GBP
- Report
- January 2023
- 98 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- January 2023
- 98 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2022
- 135 Pages
Global
From €4247EUR$4,450USD£3,558GBP
The DVT Prevention Pump market is a subset of the Cardiovascular Devices market. It is composed of devices used to prevent Deep Vein Thrombosis (DVT), a condition in which a blood clot forms in a deep vein, usually in the leg. These pumps are designed to increase blood flow in the legs, reducing the risk of clot formation. The pumps are typically used in patients who are bedridden or have limited mobility, such as those recovering from surgery or injury. The pumps are also used in patients with chronic conditions such as diabetes, obesity, and heart failure.
The DVT Prevention Pump market is highly competitive, with a variety of manufacturers offering a range of products. Companies in the market include Medtronic, Smiths Medical, B. Braun, and AngioDynamics. Show Less Read more
